Risk to bone health during treatment of endometriosis with dienogest

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Treatment for endometriosis with dienogest (DNG) associated with bone loss in 75%.
  • Clinical significance is unclear.

Why this matters

  • Endometriosis affects 10% of reproductive-aged women and is associated with pain and infertility.
  • DNG is a synthetic nortestosterone derivati...